Demonstration of SLU7 as a new cancer target
Open Access
- 2 December 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 193, 118854
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia, Innovación y Universidades (PID2022\u2013137181OB-I00)
- Ministerio de Ciencia, Innovación y Universidades (PID2019\u2013104265RB-I00)
- Ministerio de Ciencia, Innovación y Universidades (PREP2022\u2013000614)
- Ministerio de Ciencia, Innovación y Universidades (RYC2018\u2013024475\u20131)
- Agencia Estatal de Investigación
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Fundación Eugenio Rodríguez Pascual
- Fundación Científica Asociación Española Contra el Cáncer (INVES223049AREC)
- Fundación Científica Asociación Española Contra el Cáncer (PRDNA258508ROJO)
- Fundación Científica Asociación Española Contra el Cáncer (2022)
This publication has 31 references indexed in Scilit:
- Biomineralized Engineered Bacterial Outer Membrane Vesicles as cGAS-STING Nanoagonists Synergize with Lactate Metabolism Modulation to Potentiate ImmunotherapyJournal of the American Chemical Society, 2025
- Generation of tumor neoantigens by RNA splicing perturbationTrends in Cancer, 2024
- RNA therapeutics in cancer treatment2024
- A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progressionMolecular Therapy Nucleic Acids, 2022
- Turning cold tumors hot: from molecular mechanisms to clinical applicationsTrends in Immunology, 2022
- Emerging immunotherapy for HCC: A guide for hepatologistsHepatology, 2022
- Splicing Factor SLU7 Prevents Oxidative Stress‐Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver DamageHepatology, 2021
- Pharmacologic modulation of RNA splicing enhances anti-tumor immunityCell, 2021
- Therapeutic applications of AS1411 aptamer, an update reviewInternational Journal of Biological Macromolecules, 2020
- SLU7 is a survival factor for cancer cells working as a mitotic regulatorJournal of Hepatology, 2017